Adjuvant benmelstobart plus anlotinib in patients with high-risk recurrence after resection of hepatocellular carcinoma: a phase II study (ALTER-H006)
- Journal:
- Nature Communications
- Published:
- Affiliations:
- 6
- Authors:
- 10
| Institutions | Authors | Share |
|---|---|---|
| Hunan Provincial People's Hospital, China | 0.33 | |
| Hubei Cancer Hospital (HBCH), China | 0.20 | |
| Jiangxi Provincial Cancer Hospital, China | 0.20 | |
| Fujian Provincial Hospital, China | 0.20 | |
| Hunan Cancer Hospital, China | 0.03 | |
| Central South University (CSU), China | 0.03 |